{
    "doi": "https://doi.org/10.1182/blood.V128.22.5281.5281",
    "article_title": "Genomic Characterization of Paired Diagnosis and Relapse Samples from Adult Patients with B-Cell Precursor Acute Lymphoblastic Leukemia ",
    "article_date": "December 2, 2016",
    "session_type": "618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis",
    "abstract_text": "Background & Objective: Acute Lymphoblastic Leukemia (ALL) is an aggressive neoplasia characterized by a high genetic heterogeneity both at diagnosis and at relapse. Due to the high incidence of relapse in adults and the dismal prognosis beyond recurrence, diagnosis and relapse samples of adult ALL patients were carefully analyzed in order to identify genetic alterations related with drug resistance and disease progression. Patients & Methods: Paired diagnosis-relapse bone marrow samples from 5 adult B-cell precursor ALL (B-ALL) patients were analyzed (Ph+ ALL [n=2], normal karyotype [n=1], t(1;19)(q23;p13) [n=1] and t(8;13)(p21-22;q12) [n=1]). Copy Number Alterations (CNA) were studied with Multiplex Ligation-dependent Probe Amplification (MLPA, kits P-335 and P-202 from MRC-Holland, Amsterdam, Netherlands) and Affymetrix CytoScan HD arrays (Affymetrix, Santa Clara, USA). In the array analyses, only the CNA that encompassed at least 25 markers were considered significant. Results: Regarding karyotype, 2 patients (1 Ph+ and 1 t(1;19) at diagnosis) showed the same chromosomal translocations within a complex karyotype at relapse. On the contrary, the other Ph+ patient showed a normal karyotype at relapse, while 2 patients did not experience any karyotypic change. Regarding immunophenotype, 3/5 patients showed changes on antigen expression from diagnosis to relapse such as expression of markers of immaturity (CD34, TdT positivity and CD38 negativity), loss of lymphoid markers (CD20 and CD22) and/or acquisition of myeloid markers (CD33 and CD66c). Concerning CNA, all relapse samples were genetically related to the diagnosis clone (common clonal origin). All relapsed populations lost CNA detected at diagnosis and/or acquired new CNA but retained some of the CNA showed at diagnosis revealing clonal evolution from ancestral clones. CNA in B-ALL key genes involved in lymphoid development ( IKZF1 , PAX5 , EBF1,VPREB1 and BLNK ), proliferation ( CDKN2A/B , RB1, CRLF2, C-MYC and ERG ), apoptosis ( BTG1 , TP53 and ATM ), hematopoiesis transcription factors ( ETV6 and MLL ) and histone modifications ( KDM6A ) were detected, among others. Losses in 9p were the most recurrent event both at diagnosis and at relapse. CDKN2A/B deletions were observed in all relapse samples (3/5 in homozygosis) while PAX5 deletions were present in 4/5 relapsed cases. Interestingly, all relapse samples showed CNA favoring the activation and/or the transcription of proteins involved in the Akt/C-MYC signaling pathway. Another common feature (4/5 patients) were CNA affecting genes involved in drug transport such as several ABC transporter genes and genes related to drug resistance such as PRKDC and RUNX1T1 (in 3/4 of the cases, the CNA appeared exclusively at relapse or were already present at diagnosis and increased their frequency at relapse). CNA in genes that may confer stem cell characteristics ( EGR1 and USP16 ) were another recurrent event at relapse (3/5 samples, 2 of them were not present at diagnosis). CNA affecting the X/Y PAR1 region ( CRLF2 , CSF2RA and IL3RA ) or VPREB1 at 22q11.22 were detected in 3/5 relapse samples, respectively. An important apoptosis cluster at 11q21q24.2 ( BIRC2/3 , CASP1/4/5/12 , hsa-miR-34b/c , ATM and BTG4 ) was lost in 2/5 relapse samples (one of them was not detected at diagnosis and the other increased its frequency at relapse). Finally, ETV6 deletion (12p13.2) and duplication of Xq26.2q28 (containing ABCD1 , BCAP31 and genes coding for several cancer/testis antigens) were observed in 2 relapse samples. Conclusions: SNP arrays analysis of paired B-cell precursor ALL samples at diagnosis and at relapse allows the identification of genetic alterations potentially related with ALL progression. The systematic analysis of relapse samples could contribute to the identification of specific genetic targets with potential therapeutic impact for each patient (personalized medicine). Disclosures Mart\u00ednez-L\u00f3pez: Novartis: Honoraria, Speakers Bureau. Sole: Celgene: Membership on an entity's Board of Directors or advisory committees.",
    "topics": [
        "acute lymphocytic leukemia",
        "b-lymphocytes",
        "burkitt's lymphoma",
        "genome",
        "karyotype determination procedure",
        "antigens",
        "leukemia, b-cell, acute",
        "protein p16",
        "atp-binding cassette transporters",
        "bone marrow specimen"
    ],
    "author_names": [
        "Jordi Ribera",
        "Mar Mallo, PhD",
        "Lurdes Zamora, PhD",
        "Neus Solanes",
        "Susana Vives, MD",
        "Montserrat Batlle, MD",
        "Ramon Gu\u00e0rdia, MD PhD",
        "Santiago Mercadal",
        "Lourdes Escoda, MD PhD",
        "Josep F. Nomdedeu, MD PhD",
        "Marta Pratcorona",
        "Jordi Esteve, MD PhD",
        "Joaqu\u00edn Mart\u00ednez-L\u00f3pez, MD PhD",
        "Mar Tormo, MD",
        "Joaqu\u00edn S\u00e1nchez",
        "Roc\u00edo Ruiz",
        "Erica Mor\u00e1n",
        "Marta Cabez\u00f3n",
        "S\u00edlvia Marc\u00e9, PhD",
        "Diana Dom\u00ednguez",
        "Isabel Granada",
        "Jordi Junc\u00e0",
        "Eul\u00e0lia Genesc\u00e0",
        "Fuensanta Mill\u00e1, MD PhD",
        "Evarist Feliu, MD PhD",
        "Francesc Sole, PhD",
        "Josep-Maria Ribera, MD PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Jordi Ribera",
            "author_affiliations": [
                "Josep Carreras Leukaemia Research Institute, ICO-Germans Trias i Pujol Hospital, Universitat Aut\u00f2noma de Barcelona, Grup de Recerca en LAL, Badalona, Spain "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Mar Mallo, PhD",
            "author_affiliations": [
                "MDS Research Group, Institut de Recerca Contra la Leuc\u00e8mia Josep Carreras, ICO-Hospital Germans Trias i Pujol, Universitat Aut\u00f2noma de Barcelona, Badalona, Spain "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lurdes Zamora, PhD",
            "author_affiliations": [
                "Hematology Service, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autonoma de Barcelona, Badalona, Spain, Badalona, Spain "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Neus Solanes",
            "author_affiliations": [
                "MDS Research Group, Institut de Recerca Contra la Leuc\u00e8mia Josep Carreras, ICO-Hospital Germans Trias i Pujol, Universitat Aut\u00f2noma de Barcelona, Badalona, Spain "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Susana Vives, MD",
            "author_affiliations": [
                "Department of Hematology, ICO Badalona-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute. Universitat Aut\u00f2noma de Barcelona, Badalona, Spain "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Montserrat Batlle, MD",
            "author_affiliations": [
                "ICO Badalona-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute. Universitat Aut\u00f2noma de Barcelona, Badalona, Spain "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ramon Gu\u00e0rdia, MD PhD",
            "author_affiliations": [
                "Department of Hematology, ICO Girona- Hospital Josep Trueta, Girona, Spain "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Santiago Mercadal",
            "author_affiliations": [
                "Hematology, Catalan Institute of Oncology-Duran i Reynals Hospital, Hospitalet de Llobregat, Spain "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lourdes Escoda, MD PhD",
            "author_affiliations": [
                "ICO-Hospital Joan XXIII, Tarragona, Spain "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Josep F. Nomdedeu, MD PhD",
            "author_affiliations": [
                "Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marta Pratcorona",
            "author_affiliations": [
                "Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jordi Esteve, MD PhD",
            "author_affiliations": [
                "Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Joaqu\u00edn Mart\u00ednez-L\u00f3pez, MD PhD",
            "author_affiliations": [
                "Hematology Department, 12 de Octubre Hospital, Madrid, Spain "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mar Tormo, MD",
            "author_affiliations": [
                "Hospital Cl\u00ednico Universitario de Valencia, Spanish MDS Cooperative Group, Valencia, Spain "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Joaqu\u00edn S\u00e1nchez",
            "author_affiliations": [
                "Hematology Department, Reina Sof\u00eda Hospital, C\u00f3rdoba, Spain "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roc\u00edo Ruiz",
            "author_affiliations": [
                "Josep Carreras Leukaemia Research Institute, ICO-Germans Trias i Pujol Hospital, Universitat Aut\u00f2noma de Barcelona, Badalona, Spain "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Erica Mor\u00e1n",
            "author_affiliations": [
                "Josep Carreras Leukaemia Research Institute, ICO-Germans Trias i Pujol Hospital, Universitat Aut\u00f2noma de Barcelona, Badalona, Spain "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marta Cabez\u00f3n",
            "author_affiliations": [
                "Hematology Service, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leuc\u00e8mia Josep Carreras, Universitat Aut\u00f2noma de Barcelona, Badalona, Spain "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "S\u00edlvia Marc\u00e9, PhD",
            "author_affiliations": [
                "Hematology Service, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leuc\u00e8mia Josep Carreras, Universitat Aut\u00f2noma de Barcelona, Badalona, Spain "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Diana Dom\u00ednguez",
            "author_affiliations": [
                "ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leuc\u00e8mia Josep Carreras, Universitat Aut\u00f2noma de Barcelona, Badalona, Spain "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Isabel Granada",
            "author_affiliations": [
                "Hematology Department, ICO-Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Aut\u00f2noma de Barcelona., Badalona, ESP "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jordi Junc\u00e0",
            "author_affiliations": [
                "Hematology Department, ICO-Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Aut\u00f2noma de Barcelona., Badalona, Spain "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eul\u00e0lia Genesc\u00e0",
            "author_affiliations": [
                "Josep Carreras Leukaemia Research Institute, ICO-Germans Trias i Pujol Hospital, Universitat Aut\u00f2noma de Barcelona, Grup de Recerca en LAL, Badalona, Spain "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fuensanta Mill\u00e1, MD PhD",
            "author_affiliations": [
                "Hematology Service, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leuc\u00e8mia Josep Carreras, Universitat Aut\u00f2noma de Barcelona, Badalona, Spain "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Evarist Feliu, MD PhD",
            "author_affiliations": [
                "Department of Hematology, ICO Badalona-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute. Universitat Aut\u00f2noma de Barcelona, Badalona, Spain "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesc Sole, PhD",
            "author_affiliations": [
                "MDS Research Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain, Badalona, Spain "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Josep-Maria Ribera, MD PhD",
            "author_affiliations": [
                "Hematology Department, ICO-Germans Trias i Pujol. Josep Carreras Leukaemia Research Institute. Universitat Aut\u00f2noma de Barcelona, Badalona, Spain"
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-06T04:06:50",
    "is_scraped": "1"
}